UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

In vitro activity of the novel siderophore cephalosporin, cefiderocol, in Gram-negative pathogens in Europe by site of infection

Clinical microbiology and infection, 2022-03, Vol.28 (3), p.447.e1-447.e6

2022

Volltextzugriff (PDF)

Comparative activity of ceftobiprole against coagulase-negative staphylococci from the BSAC Bacteraemia Surveillance Programme, 2013–2015

European journal of clinical microbiology & infectious diseases, 2018-09, Vol.37 (9), p.1653-1659

2018

Volltextzugriff (PDF)

Predicting early appropriate therapy for patients infected by carbapenem-resistant Gram-negative pathogens in intensive care units in Italy

Antimicrobial resistance & infection control, 2024-08, Vol.13 (1), p.91-14

2024

Volltextzugriff (PDF)

Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials

Antimicrobial agents and chemotherapy, 2019-01, Vol.63 (1)

2019

Volltextzugriff (PDF)

Early improvement in severely ill patients with pneumonia treated with ceftobiprole: a retrospective analysis of two major trials

BMC infectious diseases, 2019-02, Vol.19 (1), p.195-12, Article 195

2019

Volltextzugriff (PDF)

In vitro activity of cefiderocol and comparators against isolates of Gram-negative bacterial pathogens from a range of infection sources: SIDERO‑WT‑2014−2018 studies in Spain

Journal of global antimicrobial resistance., 2021-09, Vol.26, p.292-300

2021

Volltextzugriff (PDF)

In vitro activity of cefiderocol and comparators against isolates of Gram-negative pathogens from a range of infection sources: SIDERO-WT-2014–2018 studies in Italy

Journal of global antimicrobial resistance., 2021-06, Vol.25, p.390-398

2021

Volltextzugriff (PDF)

Evaluation of the activity of cefepime/enmetazobactam against Enterobacterales bacteria collected in Europe from 2019 to 2021, including third-generation cephalosporin-resistant isolates

Journal of global antimicrobial resistance., 2024-09, Vol.38, p.71-82

2024

Volltextzugriff (PDF)

In vitro activity of cefiderocol and comparators against Gram-negative bacterial isolates from a series of surveillance studies in England: 2014–2018

Journal of global antimicrobial resistance., 2021-12, Vol.27, p.1-11

2021

Volltextzugriff (PDF)

In vitro activity of cefiderocol against Gram-negative bacterial pathogens in Germany

Journal of global antimicrobial resistance., 2022-03, Vol.28, p.12-17

2022

Volltextzugriff (PDF)

Evidence for Efficacy of Cefiderocol against OXA-48-Containing Isolates from the APEKS-NP and CREDIBLE-CR Trials

Antimicrobial agents and chemotherapy, 2022-10, Vol.66 (10), p.e0110022-e0110022

2022

Volltextzugriff (PDF)

Comment on: Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance

Journal of antimicrobial chemotherapy, 2022-09, Vol.77 (10), p.2895-2896

2022

Volltextzugriff (PDF)

Study of the glucoamylase promoter in Aspergillus niger using green fluorescent protein

Microbiology (Society for General Microbiology), 1999-03, Vol.145 ( Pt 3) (3), p.729-734

1999

Volltextzugriff (PDF)

Kinetics of alpha-amylase secretion in Aspergillus oryzae

Biotechnology and bioengineering, 1999-10, Vol.65 (1), p.76-82

1999

Volltextzugriff (PDF)

Antisense silencing of the creA gene in Aspergillus nidulans

Applied and environmental microbiology, 2000-10, Vol.66 (10), p.4579-4581

2000

Volltextzugriff (PDF)

1 – 15 von 15

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

In vitro activity of the novel siderophore cephalosporin, cefiderocol, in Gram-negative pathogens in Europe by site of infection

Comparative activity of ceftobiprole against coagulase-negative staphylococci from the BSAC Bacteraemia Surveillance Programme, 2013–2015

Predicting early appropriate therapy for patients infected by carbapenem-resistant Gram-negative pathogens in intensive care units in Italy

Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials

Early improvement in severely ill patients with pneumonia treated with ceftobiprole: a retrospective analysis of two major trials

In vitro activity of cefiderocol and comparators against isolates of Gram-negative bacterial pathogens from a range of infection sources: SIDERO‑WT‑2014−2018 studies in Spain

In vitro activity of cefiderocol and comparators against isolates of Gram-negative pathogens from a range of infection sources: SIDERO-WT-2014–2018 studies in Italy

Evaluation of the activity of cefepime/enmetazobactam against Enterobacterales bacteria collected in Europe from 2019 to 2021, including third-generation cephalosporin-resistant isolates

In vitro activity of cefiderocol and comparators against Gram-negative bacterial isolates from a series of surveillance studies in England: 2014–2018

In vitro activity of cefiderocol against Gram-negative bacterial pathogens in Germany

Evidence for Efficacy of Cefiderocol against OXA-48-Containing Isolates from the APEKS-NP and CREDIBLE-CR Trials

Comment on: Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance

Study of the glucoamylase promoter in Aspergillus niger using green fluorescent protein

Kinetics of alpha-amylase secretion in Aspergillus oryzae

Antisense silencing of the creA gene in Aspergillus nidulans

Aktive Filter

Suchergebnisse filtern